Tag - pharmaceuticals

 
 

PHARMACEUTICALS

JAPAN / Science & Health
Aug 31, 2020
Daiichi Sankyo's COVID-19 vaccine candidate selected by Japanese drug discovery body
Daiichi Sankyo Co. said on Monday that its mRNA-based COVID-19 vaccine candidate was selected for inclusion in a drug discovery program by the Japan Agency for Medical Research and Development.
Japan Times
JAPAN / Society
Aug 28, 2020
Abe vows COVID-19 vaccinations for all Japan citizens by mid-2021
In view of the coming flu season, test kits will be provided at a volume that will allow for an average of 200,000 tests to be conducted every day.
Japan Times
BUSINESS / Companies
Aug 24, 2020
Takeda to sell consumer unit to Blackstone for ¥242 billion
Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years.
Japan Times
BUSINESS
Aug 19, 2020
Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion
Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.
Japan Times
JAPAN / Science & Health
Aug 17, 2020
Philippines begins nine-month clinical trial on Avigan in COVID-19 study
The Philippines started nine-month clinical trials for Avigan on Monday to study the efficacy of the Japanese anti-flu drug against the disease caused by the new coronavirus.
Japan Times
WORLD / Science & Health
Aug 16, 2020
Coronavirus crisis has made Brazil an ideal vaccine laboratory
With a medical manufacturing infrastructure and plenty of vaccine trial volunteers, Brazil has emerged as a potentially vital player in the scramble to end the pandemic.
Japan Times
JAPAN
Aug 13, 2020
Fujifilm to complete delayed Avigan clinical trials in Japan in September
Fujifilm Holdings Corp. said Thursday it expects to complete clinical tests in Japan of the antiviral drug Avigan, a potential candidate treatment drug for COVID-19, in September, already behind schedule after a delay caused by difficulty in securing enough patient data.
Japan Times
COMMENTARY / World
Aug 10, 2020
Vaccine confronts humanity with next moral test
Who gets coronavirus protection first (and last)? Who profits (and loses)? What is “informed consent” (if it exists)? Divided societies face agonizing choices.
Japan Times
JAPAN / Science & Health
Aug 7, 2020
Japan and AstraZeneca set for deal on 100 million doses of virus vaccine
The drugmaker is expected to begin clinical trials in Japan later this month to confirm the efficacy and safety of its vaccine, currently being tested overseas.
Japan Times
COMMENTARY / World
Aug 5, 2020
Pricing COVID-19 vaccines too high could backfire on big pharma
If vaccine makers make their products too expensive for the developing world, the whole idea of intellectual property could be blown up.
Japan Times
JAPAN
Aug 4, 2020
Gargle medicine can fight coronavirus, Osaka governor says, citing limited data
The governor of Osaka Prefecture touted the powers of gargling medicine to control the coronavirus and recommended its use, sending related shares jumping and clearing shelves of disinfectants even as some questioned the findings.
Japan Times
JAPAN / Science & Health
Aug 1, 2020
Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people
The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
WORLD / Science & Health
Jul 30, 2020
Russia plans 'world's first approved' COVID-19 vaccine by Aug. 12
The conditional registration in August would still require trials to be conducted on another 1,600 people, and production is expected to begin in September.
Japan Times
BUSINESS / Companies
Jul 28, 2020
Astra to pay Daiichi up to $6 billion for new cancer drug
AstraZeneca is forging ahead to become a global oncology powerhouse, even as it works on a vaccine for the coronavirus pandemic.
Japan Times
WORLD / Science & Health
Jul 26, 2020
The supply chain to save the world is unprepared for a vaccine
The industries that shepherd goods around the world on ships, planes and trucks acknowledge they aren’t ready to handle the epic challenges of shipping an eventual COVID-19 vaccine from drugmakers to billions of people.
Japan Times
COMMENTARY / World
Jul 26, 2020
Britain's response to COVID-19 has been world class
One country has done more than any other to stop the spread of the coronavirus.
Japan Times
JAPAN / Science & Health
Jul 22, 2020
Japan approves dexamethasone as second drug for coronavirus treatment
The inexpensive and easy-to-obtain drug is used to treat a wide range of conditions including lung disease.
Japan Times
WORLD / Science & Health
Jul 21, 2020
Wave of promising study results raise hopes for coronavirus vaccines
Early data from trials of three potential COVID-19 vaccines released on Monday, including a closely watched candidate from Oxford University, increased confidence that a vaccine can train the immune system to recognize and fight the novel coronavirus without serious side effects.
Japan Times
JAPAN / Science & Health
Jul 18, 2020
Fujifilm to start another Avigan study in Kuwait following setback in Japan
The trial is to be conducted with India's Dr. Reddy's Laboratories and will involve up to 1,000 people to assess the flu drug's effectiveness against the coronavirus.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'